MET Genetic Abnormalities Unreliable for Patient Selection for Therapeutic Intervention in Oropharyngeal Squamous Cell CarcinomaLudovic Lacroix(Centre National de la Recherche Scientifique), Stéphane Temam(Institut Gustave Roussy)PLoS ONEJanuary 17, 201410.1371/journal.pone.0084319Cited by 17SaveCiteExport RISWatch citationsRelated PapersDeterminants of the outcomes of patients with cancer infected with SARS-CoV-2: results from the Gustave Roussy cohort|Nature Cancer|2020|119KEYNOTE-689: Phase 3 study of adjuvant and neoadjuvant pembrolizumab combined with standard of care (SOC) in patients with resectable, locally advanced head and neck squamous cell carcinoma.|Journal of Clinical Oncology|2019|51